---
title: "Gilead extends Arcellx tender offer expiration date"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281422486.md"
description: "Gilead Sciences has extended the expiration date for its tender offer for Arcellx shares to April 24, 5 PM ET, from the previous deadline of April 3. As of March 31, only about 7.5% of shares have been tendered. The $7.8 billion deal, approved by both companies' boards, is expected to close in Q2, with Gilead offering $115 per share in cash and a contingent value right of $5 per share."
datetime: "2026-04-01T20:53:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281422486.md)
  - [en](https://longbridge.com/en/news/281422486.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281422486.md)
generator: "portal-rs"
---

# Gilead extends Arcellx tender offer expiration date

Gilead Sciences (GILD) has extended the expiration date of its tender offer for all common shares of Arcellx (ACLX) to 5p ET on April 24. It was midnight on April 3 prior. The biotech giant noted that as of 5p ET on March 31, only ~7.5% of outstanding shares have been tendered. The deal, worth up to $7.8B, has already been approved by both compani...

### Related Stocks

- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ACLX.US](https://longbridge.com/en/quote/ACLX.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [NEOS Investment Management LLC Has $120.08 Million Position in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/298019220.md)
- [Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock](https://longbridge.com/en/news/297831169.md)
- [New HIV and Breast Cancer Wins Might Change The Case For Investing In Gilead Sciences (GILD)](https://longbridge.com/en/news/297483843.md)
- [Bamco Inc. NY Sells 12,000 Shares of Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/297281302.md)
- [Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run](https://longbridge.com/en/news/297410206.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**